On November 30, 2018 OncoCyte Corporation (NYSE American: OCX), a developer of novel, non-invasive tests for the early detection of lung cancer, reported that the Company will provide a corporate overview at the LD Micro 11th Annual Main Event Investor Conference, being held December 4-6, 2018 at the Luxe Sunset Boulevard Hotel in Los Angeles, CA (Press release, BioTime, NOV 30, 2018, View Source;p=RssLanding&cat=news&id=2378868 [SID1234531771]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

OncoCyte Corporation Presentation Details:
Date: Tuesday, December 4
Time: 8:00am Pacific Time/11:00am Eastern Time
Location: Luxe Sunset Boulevard Hotel